IP Library Granted Patent US 8,465,531
Granted Patent B2
US 8,465,531 · App. 13/074,230 · Granted Jun 18, 2013

Light therapy modality

Inventors: Antti Aunio (Oulu, FI); Juuso Nissilä (Ii, FI)
Assignee: Valkee Oy
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,465,531
App. No.
13/074,230
Granted
Jun 18, 2013
Kind
B2
Abstract

A method of light therapy includes non-invasive, intra-cranial administration of bright light via the ear canal of a subject by using a light intensity of 0.7-12 lumens, and a treatment time of 1-15 minutes. A medical device including radiation elements for directing the light via the ear canal for use in the light therapy is described.

Claims (12)

1. A method of treating a subject in need of light therapy, said method comprising

providing a medical device, comprising an optical radiation source and a light guide, for directing light directly into the ear canal of the subject,

directing non-invasively, intra-cranially via both of the subject's ear canals bright light having an intensity of 6.0-8.5 lumens for a treatment time of 8-12 minutes once a day for at least five times a week for at least three weeks, with the bright light having a primary light spectrum peak in the blue region; and

reducing depressive symptoms of the subject via direction of light directly into the ear canals of the subject.

2. The method of claim 1 , wherein the bright light has a secondary light spectrum peak in the green region.

3. The method of claim 1 , wherein the bright light is directed using at least one light-emitting ear plug which at least partially penetrates into the ear canal.

4. The method of claim 1 , including the step of showing, via functional magnetic resonance imaging (fMRI) testing, SAD-related increased functional connectivity in the subject's brain after the step of treating a subject suffering from SAD has commenced.

5. The method of claim 1 , wherein the bright light has a primary light spectrum peak between 450 and 475 nm.

6. The method of claim 2 , wherein the bright light has a secondary light spectrum peak between 495 and 570 nm.

7. The method of claim 1 , wherein the step of reducing depressive symptoms of the subject via direction of light directly into the ear canal of the subject includes treating a subject suffering from at least one of seasonal affective disorder (SAD), major depressive disorder (MDD), bipolar affective disorder, and atypical depression.

8. The method of claim 7 , including the step of treating a subject suffering from SAD during the season when SAD is symptomatic.

9. The method of claim 7 , including the step of showing, via functional magnetic resonance imaging (fMRI) testing, SAD-related increased functional connectivity in the subject's brain after the step of treating a subject suffering from SAD has commenced.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2011
From: AUNIO, ANTTI; NISSILA, JUUSO
To: VALKEE OY
Reel/Frame 026546/0198 →
Continuity (1)
Related Publication 20120253427A1 · Oct 4, 2012